Skip to main content
. Author manuscript; available in PMC: 2019 Jul 29.
Published in final edited form as: Invest New Drugs. 2012 Sep 29;31(3):714–723. doi: 10.1007/s10637-012-9876-9

Table 1.

Patient characteristics

Characteristic Number of patients %
Total number of patients treated 28
Sex
 Male 12 43
 Female 16 57
Age, years
 Median 60
 Range 19–86
ECOG PS
 0 9 32
 1 19 68
Tumor type
 Epithelial ovarian cancer 4 14
 Non-squamous NSCLC 3 11
 Squamous NSCLC 3 11
 Pancreatic cancer 3 11
 Colorectal cancer 3 11
 Sarcoma 3 11
 Othera 9 32
No. of prior chemotherapy regimens
 Median 3
 Range 1–11

ECOG Eastern Cooperative Oncology Group; PS performance status; NSCLC non-small cell lung cancer

a

Other tumor types were adenoid cystic, bladder, breast, cholangiocar-cinoma, esophageal, head and neck, prostate, peritoneal and uterine